GEN Exclusives

More »

GEN News Highlights

More »
Apr 14, 2010

Shire to Implement IDBS’ Electronic Notebook to Bolster Virtual R&D Model

  • Shire has selected IDBS to support its virtual model for pharmaceutical research. The company will use IDBS' E-WorkBook Suite along with Quantix’ infrastructure to ensure flexibility in the choice, size, and diversity of its drug research collaborations with CROs.

    By leveraging hosted services in combination with E-WorkBook, Shire reports that it will have a minimum IT footprint both in-house and at each CRO. The firm expects that this will eliminate the need for on-site data storage, provide secure access to remote data, facilitate collaboration, and reduce bottlenecks in knowledge transfer between organizations.

    E-WorkBook is a scalable, searchable, and secure environment for the capture, management, and sharing of R&D data, IDBS explains. E-WorkBook's capabilities are further enhanced by hosting in a cloud-based environment, providing extensible computing power and flexible data storage. The security model provided by E-WorkBook addresses concerns around cloud computing and data security and delivers secure import of data from multiple CROs and partners with no risk of security breaches, IDBS adds.

    “This new technology will support our remote vendor partnership relationships and enhance the transfer, review, and searching of data across our exploratory projects,” states Stephen Damment, svp of biosciences at Shire.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Patients Access to Experimental Medicines?

More »